Document is current
Any future updates will be listed below
-
Authors
Betti, Michael J. https://orcid.org/0000-0001-8394-6202
Lin, Phillip
Aldrich, Melinda C. https://orcid.org/0000-0003-3833-8448
Gamazon, Eric R.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R35HG010718)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01HG011138)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM140287)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R56AG068026)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R56AG089926)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH126459)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01CA253560)
- License Information
-
More Information
Article History
Received: 7 June 2024
Accepted: 18 February 2025
First Online: 3 April 2025
Competing interests
: Dr. Gamazon has performed consulting for Thryv Therapeutics. Dr. Gamazon is a co-inventor on patents for molecular signatures of cardiovascular phenotypes and metabolic health, and the use of RNAs as therapeutics and diagnostic biomarkers. This had no influence on the research presented in this study. The remaining authors declare no competing interests.
